Skip to main content

Tafazzin/TAZ Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP1-88511

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP1-88511
NBP1-88511-25ul

Key Product Details

Validated by

Orthogonal Validation

Species Reactivity

Validated:

Human

Cited:

Human

Predicted:

Mouse (95%), Rat (95%). Backed by our 100% Guarantee.

Applications

Validated:

Immunohistochemistry, Immunohistochemistry-Paraffin

Cited:

IF/IHC

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Concentration

Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

This antibody was developed against Recombinant Protein corresponding to amino acids: WHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQP

Reactivity Notes

Human reactivity reported in scientific literature (PMID: 24858921).

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for Tafazzin/TAZ Antibody

Immunohistochemistry-Paraffin: Tafazzin/TAZ Antibody [NBP1-88511]

Immunohistochemistry-Paraffin: Tafazzin/TAZ Antibody [NBP1-88511]

Immunohistochemistry-Paraffin: Tafazzin/TAZ Antibody [NBP1-88511] - Staining in human spleen and liver tissues.. Corresponding TAZ RNA-seq data are presented for the same tissues.
Immunohistochemistry-Paraffin: Tafazzin/TAZ Antibody [NBP1-88511]

Immunohistochemistry-Paraffin: Tafazzin/TAZ Antibody [NBP1-88511]

Immunohistochemistry-Paraffin: Tafazzin/TAZ Antibody [NBP1-88511] - Staining of human duodenum shows strong cytoplasmic positivity in glandular cells.
Immunohistochemistry-Paraffin: Tafazzin/TAZ Antibody [NBP1-88511]

Immunohistochemistry-Paraffin: Tafazzin/TAZ Antibody [NBP1-88511]

Immunohistochemistry-Paraffin: Tafazzin/TAZ Antibody [NBP1-88511] - Staining of human liver shows very weak membranous positivity in hepatocytes.

Applications for Tafazzin/TAZ Antibody

Application
Recommended Usage

Immunohistochemistry

1:20 - 1:50

Immunohistochemistry-Paraffin

1:20 - 1:50
Application Notes
For IHC-Paraffin, HIER pH 6 retrieval is recommended. IHC reported in scientific literature (PMID: 24858921).

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Formulation

PBS (pH 7.2) and 40% Glycerol

Preservative

0.02% Sodium Azide

Concentration

Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: Tafazzin/TAZ

Tafazzin / TAZ encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternative transcripts encoding additional isoforms have been described but the full-length nature of these transcripts is not known.

Alternate Names

BTHSEFE, cardiomyopathy, dilated 3A (X-linked), CMD3A, EFE2FLJ27390, G4.5endocardial fibroelastosis 2, LVNCX, Protein G4.5, tafazzin, Taz1, XAP-2

Gene Symbol

TAFAZZIN

Additional Tafazzin/TAZ Products

Product Documents for Tafazzin/TAZ Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Tafazzin/TAZ Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...